EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
8 hedge funds and large institutions have $4.55M invested in Eupraxia Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
$90.7K |
| 2 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
$3.49M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$714K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$86.8K |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
$3.84K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SC
1
Scotia Capital
Toronto,
Ontario, Canada
| $3.49M | +$73.1K | +29,230 | +2% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $714K | +$14.6K | +5,543 | +2% |
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $126K | – | – | – |
|
|
4
Goldman Sachs
New York
| $90.7K | +$90.7K | +34,500 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $86.8K | +$8.97K | +3,410 | +12% |
|
|
1WA
6
180 Wealth Advisors
Federal Way,
Washington
| $34.2K | – | – | – |
|
|
TWC
7
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3.84K | +$3.84K | +1,500 | New |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $394 | +$394 | +150 | New |
|
9
JPMorgan Chase & Co
New York
| – | -$4.88K | -1,892 | Closed |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$1.39K | -545 | Closed |
|
11
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$304 | -118 | Closed |
|